Murcko scaffold
Ring system with 4 rings and 19 atoms
16 chemicals on CompoundList share this ring system.
- Rings
- 4
- Scaffold atoms
- 19
- Chemicals
- 16
- With full pages
- 2
Scaffold SMILES
S=[PH]1OCC2OC(n3cnc4cncnc43)CC2O1
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 16 of 16 chemicals
Adenosine-3',5'-cyclic phosphorothioate
CAS 23645-17-2C10H12N5O5PS
(2S,4aR,6R,7R,7aS)-6-(6-Amino-2-Chloro-9H-Purin-9-Yl)-7-Hydroxy-2-Sulfanyltetrahydro-2H,4H-2lambda~5~-Furo[3,2-D][1,3,2]dioxaphosphinin-2-One
CAS 124854-63-3C10H11ClN5O5PS
9-[(4aR,6R,7R,7aR)-2-Hydroxy-7-methoxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-8-bromopurin-6-amine
CAS 634208-34-7C11H13BrN5O5PS
Rp-cAMPS triethylammonium salt
CAS 151837-09-1C16H27N6O5PS
8-Bromoadenosine 3',5'-cyclic monophosphorothioate, Rp-isomer sodium salt
CAS 127634-20-2C10H10BrN5NaO5PS
Sp-Cyclic AMPS (sodium salt)
CAS 142439-95-0C10H11N5NaO5PS
8-Bromoadenosine 3',5'-cyclic monophosphothiaoate, Sp-isomer sodium salt
CAS 925456-59-3C10H10BrN5NaO5PS
[(4aR,6R,7R,7aR)-6-(6-Amino-8-bromopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
CAS 788807-32-9C14H17BrN5O6PS
Sodium (4aR,6R,7R,7aS)-6-(6-amino-8-chloropurin-9-yl)-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
C10H10ClN5NaO5PS
(4aR,6R,7R,7aS)-6-(6-Amino-8-chloro-9H-purin-9-yl)-2,7-dihydroxytetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinine-2-thione
CAS 142754-27-6C10H11ClN5O5PS
Sodium, [(4aR,6R,7R,7aR)-6-(6-aminopurin-9-yl)-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
C14H17N5NaO6PS
(4aR,6R,7R,7aR)-6-(6-Amino-9H-purin-9-yl)-2-hydroxy-2-sulfanylidenetetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl butanoate
CAS 152218-23-0C14H18N5O6PS
Sodium [6-(6-amino-8-bromopurin-9-yl)-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
C14H16BrN5NaO6PS
cAMPS-Rp, triethylammonium salt
CAS 93602-66-5C16H27N6O5PS
Ethyl N-[9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]purin-6-yl]carbamate
CAS 152218-24-1C13H16N5O7PS
Sodium 6-(6-amino-8-bromopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol
C10H11BrN5NaO5PS+